What is the interaction between clarithromycin (Klacid) and sertraline?

Clarithromycin and Sertraline Interaction

Avoid combining clarithromycin (Klacid) with sertraline when possible, or use with extreme caution and close monitoring for QT prolongation and serotonin syndrome. Both drugs independently prolong the QT interval, and clarithromycin can increase sertraline levels through CYP enzyme inhibition, creating a potentially dangerous combination.

Primary Concerns

QT Prolongation Risk

Both medications carry QT prolongation risk, which is additive when combined:

• Clarithromycin is a macrolide antibiotic that prolongs the QT interval and should not be given to patients with history of QT prolongation, ventricular arrhythmias, or hypokalemia 1
• Sertraline is considered a low-risk SSRI for QT prolongation (much lower risk than citalopram/escitalopram), with negligible risk at therapeutic doses 2, 3
• The 2023 Canadian cardiovascular guidelines specifically note that macrolides (including clarithromycin) are among the "anti's" to remember for QT prolongation risk 2

Pharmacokinetic Interaction

Clarithromycin is a strong CYP3A4 inhibitor 4, 5, 6, which can increase levels of drugs metabolized by this pathway. While sertraline is primarily metabolized by other pathways, clarithromycin's broad inhibitory effects on multiple CYP enzymes (CYP3A4, CYP2C19, CYP2C9, CYP2D6) 5 create potential for interaction 7.

Serotonin Syndrome Risk

Although not directly documented for this specific combination, combining serotonergic agents increases risk of serotonin syndrome 3, 8. Clarithromycin's ability to increase sertraline levels theoretically amplifies this risk.

Clinical Management Algorithm

If clarithromycin must be used:

1. Assess baseline risk factors:

   • Check baseline ECG if patient has any cardiac history, electrolyte abnormalities, or is taking other QT-prolonging drugs 2
   • Measure potassium and magnesium levels (correct if low)
   • Review all medications for additional QT-prolonging agents
   • Assess for cardiac disease, especially in elderly or women (higher risk) 2

2. Consider alternatives first:

   • Use azithromycin (lowest macrolide risk for QT prolongation) 2
   • Use non-macrolide antibiotics like penicillins or cephalosporins if clinically appropriate 2

3. If combination unavoidable:

   • Obtain ECG before starting clarithromycin and 2 weeks after initiation 9
   • Monitor for QTc >500 ms or increase >60-70 ms from baseline 2
   • Watch for serotonin syndrome symptoms: confusion, agitation, tremors, hyperreflexia, autonomic instability, especially in first 24-48 hours 3, 8
   • Consider temporarily reducing sertraline dose during clarithromycin course
   • Limit clarithromycin duration to shortest effective course (typically 7 days) 4

4. Monitor for adverse effects:

   • Mental status changes, confusion, or delirium 7, 10
   • Cardiac symptoms (palpitations, syncope)
   • Serotonergic symptoms (agitation, tremor, diaphoresis, diarrhea)

Important Caveats

• Women and elderly patients are at higher risk for drug-induced QT prolongation 2
• The risk is highest when QTc exceeds 500 ms or increases by >60-70 ms, particularly when this develops rapidly 2
• Sertraline has significantly lower QT risk compared to citalopram/escitalopram, making it one of the safer SSRIs in this context 2, 3
• Case reports exist of serious adverse events (including delirium) when clarithromycin is combined with other serotonergic drugs like fluoxetine 7
• Clarithromycin achieves maximal CYP3A4 inhibition within 1-4 days at 500 mg twice daily 6

Bottom Line

Preferentially choose azithromycin or a non-macrolide antibiotic when treating infections in patients on sertraline. If clarithromycin is clinically necessary, obtain baseline ECG in at-risk patients, monitor closely for QT prolongation and serotonergic symptoms, and use the shortest effective antibiotic course 2, 1.